Combined therapy with RAD001 e BEZ235 overcomes resistance of PET immortalized cell lines to mTOR inhibition

Pancreatic endocrine tumors (PETs) are characterised by an indolent behaviour in terms of tumor growth. However, most patients display metastasis at diagnosis and no cure is currently available. Since the PI3K/AKT/mTOR axis is deregulated in PETs, the mTOR inhibitor RAD001 represents the first line...

Descripción completa

Detalles Bibliográficos
Autores principales: Passacantilli, Ilaria, Capurso, Gabriele, Archibugi, Livia, Calabretta, Sara, Caldarola, Sara, Loreni, Fabrizio, Fave, Gianfranco Delle, Sette, Claudio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2014
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4170632/
https://www.ncbi.nlm.nih.gov/pubmed/25026292

Ejemplares similares

Ejemplares similares